Author

Setareh H. Moghadam

Observed names: S. H. Moghadam, Setareh Moghadam

Institution: Salk Institute for Biological Studies

Observed institutions: Salk Institute for Biological Studies, Howard Hughes Medical Institute, University of California San Diego

OpenAlex ID: A5085310100

Glycinergic Projection Neurons of the Cerebellum

2009 · Martha W. Bagnall, Brian Zingg, et al. · Journal of Neuroscience · 157

Multiple Types of Cerebellar Target Neurons and Their Circuitry in the Vestibulo-ocular Reflex

2011 · M. Shin, S. H. Moghadam, et al. · Journal of Neuroscience · 78

Mechanisms of Sustained High Firing Rates in Two Classes of Vestibular Nucleus Neurons: Differential Contributions of Resurgent Na, Kv3, and BK Currents

2010 · Aryn H. Gittis, Setareh H. Moghadam, et al. · Journal of Neurophysiology · 78

Corticotropin‐releasing factor receptor‐1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease

2015 · Cheng Zhang, Ching‐Chang Kuo, et al. · Alzheimer s & Dementia · 56

Differential Effects of Meal Challenges on Cognition, Metabolism, and Biomarkers for Apolipoprotein E ɛ 4 Carriers and Adults with MildCognitive Impairment

2015 · Angela J. Hanson, Jennifer L. Bayer, et al. · Journal of Alzheimer s Disease · 47

BK Channels Are Required for Multisensory Plasticity in the Oculomotor System

2016 · Alexandra B. Nelson, Michael Faulstich, et al. · Neuron · 34

Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials

2014 · Michael C. Donohue, Setareh H. Moghadam, et al. · Alzheimer s & Dementia · 30

Intrinsic physiology of identified neurons in the prepositus hypoglossi and medial vestibular nuclei

2011 · Kristine E. Kolkman, Setareh H. Moghadam, et al. · Journal of Vestibular Research · 30

Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer's Disease Transgenic Mouse Model

2015 · Cheng Zhang, Ching-Chang Kuo, et al. · Journal of Alzheimer s Disease · 16

O2‐05‐06: Crf receptor 1 antagonism as a disease‐modifying therapy for Alzheimer's disease: Preclincal data on pathology and cognitive and synaptic deficits

2015 · Cheng Zhang, Ching-Chang Kuo, et al. · Alzheimer s & Dementia · 1

Oral: the Effect of L-carnitine Supplementation on Serum Level of Mirna-217 in Non-alcoholic Steatohepatitis Patients

2014 · Setareh H. Moghadam, Mohsen Nematy, et al.

P4–355: Factors that influence use of plasma beta‐amyloid as a biomarker of Alzheimer's disease

2013 · Robert A. Rissman, Michael Donohue, et al. · Alzheimer s & Dementia

Works count: 12

Citation count: 527

H-index: 9

I10-index: 9